Clinical Trials Browser

Phase 2/3 × Obesity × 90 days × Clear all

NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Terminated

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight